Form4insider filings, from the source

SEC Form 4 · accession 0001654954-18-010714

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Myron Kaplan
Director
Period of report
Oct 1, 2018
Accepted (ET)
Oct 1, 2018 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———294,166D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1$0.00Oct 1, 2018A10,000A——Common Stock10,00010,000D
Stock Option (Right to Buy Common Stock)F2$0.57holding————Feb 16, 2028Common Stock40,00040,000D
Restricted Stock UnitsF3—holding—————Common Stock10,00010,000D
Restricted Stock UnitsF3—holding—————Common Stock12,00012,000D
Restricted Stock UnitsF4—holding—————Common STock5,0005,000D
Stock Option (Right to Buy Common Stock)F5$2.24holding————Feb 21, 2027Common Stock40,00040,000D
Stock Option (Right to Buy Common Stock)F6$4.28holding————Apr 28, 2026Common Stock50,00050,000D

Explanation of responses